Home NDC 0071-0805-40 Neurontin
Product NDC 0071-0805
Requested package NDC 0071-0805-40
11-digit product format 000710805
Labeler code 0071
Product ID 0071-0805_e730d5df-d47b-4d7f-ae3b-bd449f6b1213
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name gabapentin
Dosage form CAPSULE
Route ORAL
Labeler Parke-Davis Div of Pfizer Inc
Application NDA020235
Marketing category NDA
Marketing start 1993-12-30
Marketing end 2027-04-30
Substance GABAPENTIN
Active strength 300 mg/1
Pharmacologic classes Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC exclude flag No
Current FDA listing Yes Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 12 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Snapshot, Source SHA-256 table Captured / source date Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 557ba5c1ecfa…9c80585c8c6e…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N020235-001 NEURONTIN GABAPENTIN 100MG CAPSULE / ORAL AB RLD 1993-12-30 N020235-002 NEURONTIN GABAPENTIN 300MG CAPSULE / ORAL AB RLD 1993-12-30 N020235-003 NEURONTIN GABAPENTIN 400MG CAPSULE / ORAL AB RLD, RS 1993-12-30
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 3 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 4 · 123 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N020235-001 NEURONTIN 100MG CAPSULE / ORAL AB RLD 1993-12-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N020235-002 NEURONTIN 300MG CAPSULE / ORAL AB RLD 1993-12-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N020235-003 NEURONTIN 400MG CAPSULE / ORAL AB RLD, RS 1993-12-30 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020235-001 NEURONTIN 100MG CAPSULE / ORAL AB RLD 1993-12-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020235-002 NEURONTIN 300MG CAPSULE / ORAL AB RLD 1993-12-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020235-003 NEURONTIN 400MG CAPSULE / ORAL AB RLD, RS 1993-12-30 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N020235-001 NEURONTIN 100MG CAPSULE / ORAL AB RLD 1993-12-30 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N020235-002 NEURONTIN 300MG CAPSULE / ORAL AB RLD 1993-12-30 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N020235-003 NEURONTIN 400MG CAPSULE / ORAL AB RLD, RS 1993-12-30 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N020235-001 NEURONTIN 100MG CAPSULE / ORAL AB RLD 1993-12-30 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N020235-002 NEURONTIN 300MG CAPSULE / ORAL AB RLD 1993-12-30 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N020235-003 NEURONTIN 400MG CAPSULE / ORAL AB RLD, RS 1993-12-30 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N020235-001 NEURONTIN 100MG CAPSULE / ORAL AB RLD 1993-12-30 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N020235-002 NEURONTIN 300MG CAPSULE / ORAL AB RLD 1993-12-30 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N020235-003 NEURONTIN 400MG CAPSULE / ORAL AB RLD, RS 1993-12-30 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N020235-001 NEURONTIN 100MG CAPSULE / ORAL AB RLD 1993-12-30 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N020235-002 NEURONTIN 300MG CAPSULE / ORAL AB RLD 1993-12-30 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N020235-003 NEURONTIN 400MG CAPSULE / ORAL AB RLD, RS 1993-12-30 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N020235-001 NEURONTIN 100MG CAPSULE / ORAL AB RLD 1993-12-30 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N020235-002 NEURONTIN 300MG CAPSULE / ORAL AB RLD 1993-12-30 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N020235-003 NEURONTIN 400MG CAPSULE / ORAL AB RLD, RS 1993-12-30 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N020235-001 NEURONTIN 100MG CAPSULE / ORAL AB RLD 1993-12-30 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N020235-002 NEURONTIN 300MG CAPSULE / ORAL AB RLD 1993-12-30 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N020235-003 NEURONTIN 400MG CAPSULE / ORAL AB RLD, RS 1993-12-30 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N020235-001 NEURONTIN 100MG CAPSULE / ORAL AB RLD 1993-12-30 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N020235-002 NEURONTIN 300MG CAPSULE / ORAL AB RLD 1993-12-30 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N020235-003 NEURONTIN 400MG CAPSULE / ORAL AB RLD, RS 1993-12-30 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N020235-001 NEURONTIN 100MG CAPSULE / ORAL AB RLD 1993-12-30 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N020235-002 NEURONTIN 300MG CAPSULE / ORAL AB RLD 1993-12-30 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N020235-003 NEURONTIN 400MG CAPSULE / ORAL AB RLD, RS 1993-12-30 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N020235-001 NEURONTIN 100MG CAPSULE / ORAL AB RLD 1993-12-30 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N020235-002 NEURONTIN 300MG CAPSULE / ORAL AB RLD 1993-12-30 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N020235-003 NEURONTIN 400MG CAPSULE / ORAL AB RLD, RS 1993-12-30 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N020235-001 NEURONTIN 100MG CAPSULE / ORAL AB RLD 1993-12-30 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N020235-002 NEURONTIN 300MG CAPSULE / ORAL AB RLD 1993-12-30 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N020235-003 NEURONTIN 400MG CAPSULE / ORAL AB RLD, RS 1993-12-30 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N020235-001 NEURONTIN 100MG CAPSULE / ORAL AB RLD 1993-12-30 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N020235-002 NEURONTIN 300MG CAPSULE / ORAL AB RLD 1993-12-30 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N020235-003 NEURONTIN 400MG CAPSULE / ORAL AB RLD, RS 1993-12-30 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N020235-001 NEURONTIN 100MG CAPSULE / ORAL AB RLD 1993-12-30 8072bd15b7f6…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 4 · 123 observed states.
Additional Listing Data#
Finished product Yes
Brand name base Neurontin Active Ingredients# Ingredient, Strength table Ingredient Strength GABAPENTIN 300 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 6CW7F3G59X Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 12 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 105028 Internal RxNorm lookup 105029 Internal RxNorm lookup 105030 Internal RxNorm lookup 261280 Internal RxNorm lookup 261281 Internal RxNorm lookup 283523 Internal RxNorm lookup 310430 Internal RxNorm lookup 310431 Internal RxNorm lookup 310432 Internal RxNorm lookup 310433 Internal RxNorm lookup 310434 Internal RxNorm lookup 351973 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 0071-0805-24 Neurontin 100 in 1 BOTTLE CAPSULE 100 47 0071-0805-40 Neurontin 50 in 1 CARTON CAPSULE 50 47 0071-0805-40 Neurontin 1 in 1 BLISTER PACK CAPSULE 1 47
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded GABAPENTIN ACTIVE INGREDIENT 6CW7F3G59X NEURONTIN (GABAPENTIN) CAPSULE NEURONTIN (GABAPENTIN) TABLET, FILM COATED NEURONTIN (GABAPENTIN) SOLUTION [PARKE-DAVIS DIV OF PFIZER INC] 27 GABAPENTIN ACTIVE MOIETY 6CW7F3G59X NEURONTIN (GABAPENTIN) CAPSULE NEURONTIN (GABAPENTIN) TABLET, FILM COATED NEURONTIN (GABAPENTIN) SOLUTION [PARKE-DAVIS DIV OF PFIZER INC] 27 CANDELILLA WAX INACTIVE INGREDIENT WL0328HX19 NEURONTIN (GABAPENTIN) CAPSULE NEURONTIN (GABAPENTIN) TABLET, FILM COATED NEURONTIN (GABAPENTIN) SOLUTION [PARKE-DAVIS DIV OF PFIZER INC] 27 COPOVIDONE K25-31 INACTIVE INGREDIENT D9C330MD8B NEURONTIN (GABAPENTIN) CAPSULE NEURONTIN (GABAPENTIN) TABLET, FILM COATED NEURONTIN (GABAPENTIN) SOLUTION [PARKE-DAVIS DIV OF PFIZER INC] 27 FD&C BLUE NO. 2 INACTIVE INGREDIENT L06K8R7DQK NEURONTIN (GABAPENTIN) CAPSULE NEURONTIN (GABAPENTIN) TABLET, FILM COATED NEURONTIN (GABAPENTIN) SOLUTION [PARKE-DAVIS DIV OF PFIZER INC] 27 FERRIC OXIDE RED INACTIVE INGREDIENT 1K09F3G675 NEURONTIN (GABAPENTIN) CAPSULE NEURONTIN (GABAPENTIN) TABLET, FILM COATED NEURONTIN (GABAPENTIN) SOLUTION [PARKE-DAVIS DIV OF PFIZER INC] 27 FERRIC OXIDE YELLOW INACTIVE INGREDIENT EX438O2MRT NEURONTIN (GABAPENTIN) CAPSULE NEURONTIN (GABAPENTIN) TABLET, FILM COATED NEURONTIN (GABAPENTIN) SOLUTION [PARKE-DAVIS DIV OF PFIZER INC] 27 GELATIN INACTIVE INGREDIENT 2G86QN327L NEURONTIN (GABAPENTIN) CAPSULE NEURONTIN (GABAPENTIN) TABLET, FILM COATED NEURONTIN (GABAPENTIN) SOLUTION [PARKE-DAVIS DIV OF PFIZER INC] 27 GLYCERIN INACTIVE INGREDIENT PDC6A3C0OX NEURONTIN (GABAPENTIN) CAPSULE NEURONTIN (GABAPENTIN) TABLET, FILM COATED NEURONTIN (GABAPENTIN) SOLUTION [PARKE-DAVIS DIV OF PFIZER INC] 27 HYDROXYPROPYL CELLULOSE (TYPE H) INACTIVE INGREDIENT RFW2ET671P NEURONTIN (GABAPENTIN) CAPSULE NEURONTIN (GABAPENTIN) TABLET, FILM COATED NEURONTIN (GABAPENTIN) SOLUTION [PARKE-DAVIS DIV OF PFIZER INC] 27 LACTOSE INACTIVE INGREDIENT J2B2A4N98G NEURONTIN (GABAPENTIN) CAPSULE NEURONTIN (GABAPENTIN) TABLET, FILM COATED NEURONTIN (GABAPENTIN) SOLUTION [PARKE-DAVIS DIV OF PFIZER INC] 27 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 NEURONTIN (GABAPENTIN) CAPSULE NEURONTIN (GABAPENTIN) TABLET, FILM COATED NEURONTIN (GABAPENTIN) SOLUTION [PARKE-DAVIS DIV OF PFIZER INC] 27 POLOXAMER 407 INACTIVE INGREDIENT TUF2IVW3M2 NEURONTIN (GABAPENTIN) CAPSULE NEURONTIN (GABAPENTIN) TABLET, FILM COATED NEURONTIN (GABAPENTIN) SOLUTION [PARKE-DAVIS DIV OF PFIZER INC] 27 STARCH, CORN INACTIVE INGREDIENT O8232NY3SJ NEURONTIN (GABAPENTIN) CAPSULE NEURONTIN (GABAPENTIN) TABLET, FILM COATED NEURONTIN (GABAPENTIN) SOLUTION [PARKE-DAVIS DIV OF PFIZER INC] 27 TALC INACTIVE INGREDIENT 7SEV7J4R1U NEURONTIN (GABAPENTIN) CAPSULE NEURONTIN (GABAPENTIN) TABLET, FILM COATED NEURONTIN (GABAPENTIN) SOLUTION [PARKE-DAVIS DIV OF PFIZER INC] 27 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP NEURONTIN (GABAPENTIN) CAPSULE NEURONTIN (GABAPENTIN) TABLET, FILM COATED NEURONTIN (GABAPENTIN) SOLUTION [PARKE-DAVIS DIV OF PFIZER INC] 27 WATER INACTIVE INGREDIENT 059QF0KO0R NEURONTIN (GABAPENTIN) CAPSULE NEURONTIN (GABAPENTIN) TABLET, FILM COATED NEURONTIN (GABAPENTIN) SOLUTION [PARKE-DAVIS DIV OF PFIZER INC] 27 XYLITOL INACTIVE INGREDIENT VCQ006KQ1E NEURONTIN (GABAPENTIN) CAPSULE NEURONTIN (GABAPENTIN) TABLET, FILM COATED NEURONTIN (GABAPENTIN) SOLUTION [PARKE-DAVIS DIV OF PFIZER INC] 27
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0071-0805 NEURONTIN (GABAPENTIN) CAPSULE NEURONTIN (GABAPENTIN) TABLET, FILM COATED NEURONTIN (GABAPENTIN) SOLUTION [PARKE-DAVIS DIV OF PFIZER INC] 42 Current NDC, Legacy NDC, 3 package rows 20241009_ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 0071-0805-40 00071080540 50 BLISTER PACK in 1 CARTON (0071-0805-40) > 1 CAPSULE in 1 BLISTER PACK 50 blister pack 1993-12-30 0000-00-00 No No Current